NuCana (NCNA) Current Leases (2019 - 2025)
NuCana (NCNA) reported Current Leases of $872589.0 for Q4 2025, up 481.07% on a YoY basis from $150169.7 in Q4 2024, and up 750.88% sequentially from $102551.5 in Q3 2025.
NuCana (NCNA) Current Leases (2019 - 2025) Analysis & Trends
NuCana (NCNA) has 7 years of Current Leases data on file, last reported at $872589.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 481.07% year-over-year to $872589.0; the trailing twelve-month figure through Dec 2025 stood at $872589.0 (up 481.07% YoY), and the FY2025 full-year result was $864942.8, up 478.33% from the prior year.
- Current Leases improved to $872589.0 in Q4 2025, from $102551.5 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $872589.0 in Q4 2025 to a low of $102551.5 in Q3 2025.
- A 5-year average of $301718.2 and a median of $267357.7 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 61.34% in 2022 and soared 481.07% in 2025, its largest moves.
- Tracing NCNA's Current Leases over 5 years: stood at $279038.2 in 2021, then soared by 66.46% to $464479.6 in 2022, then sank by 44.95% to $255677.3 in 2023, then tumbled by 41.27% to $150169.7 in 2024, then soared by 481.07% to $872589.0 in 2025.
- Business Quant data shows NCNA's Current Leases at $872589.0 in Q4 2025, $102551.5 in Q3 2025, and $105389.6 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 872,589.03 |
| Sep 30, 2025 | 102,551.52 |
| Jun 30, 2025 | 105,389.61 |
| Mar 31, 2025 | 124,690.55 |
| Dec 31, 2024 | 150,169.72 |
| Sep 30, 2024 | 176,704.82 |
| Jun 30, 2024 | 194,381.99 |
| Mar 31, 2024 | 218,185.13 |
| Dec 31, 2023 | 255,677.29 |
| Sep 30, 2023 | 291,337.50 |
| Jun 30, 2023 | 357,889.86 |
| Mar 31, 2023 | 410,842.22 |
| Dec 31, 2022 | 464,479.62 |
| Sep 30, 2022 | 540,953.67 |
| Jun 30, 2022 | 148,599.08 |
| Mar 31, 2022 | 213,351.88 |
| Dec 31, 2021 | 279,038.20 |
| Sep 30, 2021 | 334,995.75 |
| Jun 30, 2021 | 384,375.27 |
| Mar 31, 2021 | 408,160.55 |